施馬倫貝格病毒治療市場：按治療類型、動物類型、按最終用戶、按地區

Schmallenberg Virus Treatment Market, By Treatment Type, By Animal Type, By End User, By Geography

出版日期: 2025年03月26日 | 出版商:

Coherent Market Insights | 英文 130 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

施馬倫貝格病毒治療市場規模預計在 2025 年為 1.292 億美元，預計到 2032 年將達到 2.272 億美元，2025 年至 2032 年的年複合成長率為 8.4%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	1.292億美元
效能數據	2020-2024	預測期	2025-2032
預測期間：2025年至2032年的年複合成長率	8.40%	2032年價值預測	2.272億美元

施馬倫貝格病毒是一種主要感染歐洲反芻動物的病原體，以其2011年在德國首次發現的小鎮命名。此病毒主要透過媒介三帶喙庫蚊傳播。受感染的牛、羊、山羊等牲畜常出現輕度至中度症狀，如發燒、產乳量減少、生育能力下降等。在懷孕的牲畜中，尤其是牛和母羊，該病毒可導致後代先天畸形和死產，對畜牧生產構成重大威脅。施馬倫貝格病毒已蔓延至歐洲各國，受感染的農場因生產力下降和繁殖問題而遭受經濟損失。目前尚無針對該動物傳播病毒的特效治療方法，但預防和控制策略包括在可能的情況下控制媒介，並在一些地區實施疫苗接種計畫。值得注意的是，該病毒主要感染動物，不認為對人類健康造成重大風險。正在進行的研究和開發重點是了解病毒、闡明其傳播動態、開發更有效的疫苗和控制措施，以保護牲畜和農業免受其影響。

預防和控制施馬倫貝格病毒需要採取一系列措施，包括控制媒介以減少耳蟎暴露、進行疫苗接種計劃（在可能的情況下）以及密切監測牲畜的感染徵兆。需要強調的是，該病毒主要感染牲畜，不會對人類健康造成重大風險。正在進行的研究和開發旨在更好地了解該病毒及其傳播動態，並開發更有效的疫苗和控制策略，從而減少其對牲畜和歐洲農業部門的影響。

市場動態

預計在預測期內，相關發展、認知度的提升以及研發工作將推動全球施馬倫貝格病毒治療市場的成長。此外，支持性措施也預計將在預測期內促進全球施馬倫貝格病毒治療市場的成長。疫苗研發、抗病毒藥物、支持性護理解決方案以及診斷工具預計將在預測期內為全球施馬倫貝格病毒治療市場帶來成長機會。

然而，有限的治療選擇、疫苗開發的複雜性以及較低的經濟獎勵預計將在預測期內阻礙施馬倫貝格病毒治療市場的成長。

研究的主要特點

本報告對施馬倫貝格病毒治療市場進行了詳細分析，並以 2024 年為基準年，展示了預測期 2025-2032 的市場規模和年複合成長率。
它還強調了各個領域的潛在商機，並說明了該市場的引人注目的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的主要考察。
施馬倫貝格病毒治療市場的主要企業是根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數進行的分析。
本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
施馬倫貝格病毒治療市場報告迎合了該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員將透過施馬倫貝格病毒治療市場分析中使用的各種策略矩陣更輕鬆地做出決策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 129.2 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	8.40%	2032 Value Projection:	USD 227.2 Mn

Schmallenberg virus is a pathogen that primarily affects ruminant livestock in Europe, with its name derived from the German town where it was first identified in 2011. This virus is mainly transmitted by Culicoides midges, which serve as vectors for its spread. When livestock, such as cattle, sheep, and goats, are infected, they often display mild to moderate symptoms, including fever, reduced milk production, and decreased fertility. In pregnant animals, particularly cows and ewes, the virus can lead to congenital malformations in the offspring and stillbirths, posing a significant threat to livestock production.The Schmallenberg virus has extended its reach to various European countries, causing economic losses for affected farms due to reduced productivity and reproductive issues. While there is no specific treatment for the virus in animals, prevention and control strategies involve vector control, when possible, as well as vaccination programs in some regions. Notably, the virus primarily affects animals and is not considered a substantial risk to human health. Ongoing research efforts continue to focus on understanding the virus, its transmission dynamics, and the development of more effective vaccines and control measures to safeguard livestock and the agricultural industry from its impact.

Preventing and controlling the Schmallenberg virus involves various measures, including vector control to limit midge exposure, vaccination programs where available, and vigilant monitoring for signs of infection in livestock. It's worth emphasizing that the virus primarily affects animals and does not pose a significant risk to human health. Ongoing research efforts are dedicated to better understanding the virus, its transmission dynamics, and the development of more effective vaccines and control strategies to mitigate its impact on livestock and the agricultural sector in Europe.

Market Dynamics:

Emerging outbreaks, growing awareness, and research and development are anticipated to drive growth of the global Schmallenberg virus treatment market over the forecast period. Moreover, supportive measures are also expected to boost the growth of the global Schmallenberg virus treatment market over the forecast period. Vaccine development, antiviral drugs, supportive care solutions and diagnostic tools are expected to create growth opportunities for the global Schmallenberg virus treatment market during the forecast period.

However, limited treatment options, the complexity of vaccine development, and low economic incentives are expected to hamper growth of the Schmallenberg virus treatment market over the forecast period.

Key features of the study:

This report provides in-depth analysis of the Schmallenberg virus treatment market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the Schmallenberg virus treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Boehringer Ingelheim, Zoetis, MSD Animal Health (Merck Animal Health), Elanco Animal Health, Ceva Sante Animale, Virbac, Bayer Animal Health, Vetoquinol, Huvepharma, IDT Biologika, Heska Corporation, Dechra Pharmaceuticals, Phibro Animal Health, Neogen Corporation
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The Schmallenberg virus treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Schmallenberg virus treatment market

Schmallenberg Virus Treatment Market Detailed Segmentation:

By Treatment Type:
- Antiviral Drugs
- Anti-inflammatory Drugs
- Analgesics
- Vaccines
- Others
By Animal Type:
- Cattle
- Sheep
- Goats
- Others
By End User:
- Veterinary Hospitals and Clinics
- Research Institutions
- Veterinary Pharmacies and Drug Store
- Others
By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Company Profile:
- Boehringer Ingelheim
- Zoetis
- MSD Animal Health (Merck Animal Health)
- Elanco Animal Health
- Ceva Sante Animale
- Virbac
- Bayer Animal Health
- Vetoquinol
- Huvepharma
- IDT Biologika
- Heska Corporation
- Dechra Pharmaceuticals
- Phibro Animal Health
- Neogen Corporation

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Schmallenberg Virus Treatment, By Treatment Type
- Market Schmallenberg Virus Treatment, By Animal Type
- Market Schmallenberg Virus Treatment, By End User
- Market Schmallenberg Virus Treatment, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
Emerging Outbreaks
Growing Awareness
Research and Development
Supportive Measures
- Restraints
Limited Treatment Options
Complexity of Vaccine Development
- Opportunities
Vaccine development
Antiviral Drugs
Supportive Care Solutions
Diagnostic Tools
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Schmallenberg Virus Treatment Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Schmallenberg Virus Treatment Market, By Treatment Type, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Antiviral Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Anti-inflammatory Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Analgesics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Schmallenberg Virus Treatment Market, By Animal Type, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Cattle
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
Sheep
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
Goats
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)

7. Schmallenberg Virus Treatment Market, By End User, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Veterinary Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Research Institutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Veterinary Pharmacies and Drug Store
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

8. Schmallenberg Virus Treatment Market, By Region, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, By Country, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Country 2021 -2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Mn)
  - GCC
  - Israel
  - North Africa
  - Central Africa
  - Rest of Middle East & Africa

9. Competitive Landscape

Boehringer Ingelheim
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Zoetis
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
MSD Animal Health (Merck Animal Health)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Elanco Animal Health
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Ceva Sante Health
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Virbac
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Bayer Animal Health
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Vetoquinol
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Huvepharma
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
IDT Biologika
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Heska Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Dechra Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Phibro Animal Health
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Nogen Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views